Adage Capital Partners’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-100,000
| Closed | -$4.77M | – | 1180 |
|
|
2021
Q4 | $4.77M | Sell |
100,000
-14,822
| -13% | -$707K | 0.01% | 820 |
|
|
2021
Q3 | $7.63M | Sell |
114,822
-85,178
| -43% | -$5.66M | 0.02% | 774 |
|
|
2021
Q2 | $15.6M | Buy |
200,000
+100,000
| +100% | +$7.8M | 0.03% | 555 |
|
|
2021
Q1 | $9.46M | Sell |
100,000
-75,000
| -43% | -$7.09M | 0.02% | 701 |
|
|
2020
Q4 | $21.3M | Sell |
175,000
-25,000
| -13% | -$3.05M | 0.05% | 403 |
|
|
2020
Q3 | $17.5M | Buy |
200,000
+25,000
| +14% | +$2.18M | 0.04% | 413 |
|
|
2020
Q2 | $11.3M | Buy |
175,000
+50,000
| +40% | +$3.23M | 0.03% | 507 |
|
|
2020
Q1 | $5.58M | Buy |
125,000
+100,000
| +400% | +$4.47M | 0.02% | 561 |
|
|
2019
Q4 | $1.56M | Sell |
25,000
-175,000
| -88% | -$10.9M | ﹤0.01% | 666 |
|
|
2019
Q3 | $7.52M | Hold |
200,000
| – | – | 0.02% | 575 |
|
|
2019
Q2 | $8.14M | Buy |
+200,000
| New | +$8.14M | 0.02% | 554 |
|